• Find a Doctor
  • News
  • Events
  • Videos
  • Careers
  • Locations
  • Make a Gift
  • 212-263-4432
  • Follow us on Facebook. Opens in a new tab
  • Follow us on Twitter. Opens in a new tab
  • Follow us on Youtube. Opens in a new tab
  • Follow us on Instagram. Opens in a new tab
  • Follow us on LinkedIn. Opens in a new tab
Clinical Trials at NYU Medical Centre

Perlmutter Cancer Center

Clinical Trials & Research Studies

  • Clinical Trials
  • FAQs
  • Login
  • Perlmutter Cancer Center
Start Over

1 clinical trials found.

  • A Phase 1 First-in Human Multi-Center Open Label Dose-Escalation Study to Determine the Safety Tolerability Pharmacokinetics and RP2D of ABBV-151 as a Single Agent and in Combination with ABBV-181 in Subjects with Locally Advanced or Metastatic Solid Tumors (AbbVie M19-345)

    The purpose of the study is to look at safety and efficacy of study drug ABBV-151 alone and in combination with study drug ABBV-181. We ...
    Phase phase 1 icon interventional phase icon Interventional

 

  • «
  • ←
  • 1
  • →
  • »
  • NYU Langone Health
  • Library
  • Policies & Disclaimers

Make a Gift »


Powered By Trialx iConnect logo